Skip to main content

Emtricitabine and Tenofovir Disoproxil Fumarate

NDC 50090-6494 · A-S Medication Solutions

Generic nameEmtricitabine and Tenofovir Disoproxil Fumarate
Dosage formTABLET, FILM COATED
RouteORAL
Active ingredient(s)EMTRICITABINE, TENOFOVIR DISOPROXIL FUMARATE
Strength200; 300 mg/1; mg/1
Pharmacologic classHepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS], Nucleosides [CS]
Marketing categoryANDA

Packages

50090-6494-1 — 30 TABLET, FILM COATED in 1 BOTTLE (50090-6494-1)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

42291-980 — Emtricitabine and Tenofovir Disoproxil Fumarate, 42385-801 — emtricitabine, rilpivirine and tenofovir disoproxil fumarate, 42385-915 — Efavirenz, emtricitabine and tenofovir disoproxil fumarate, 42385-928 — Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate, 42385-929 — Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate, 42385-953 — Emtricitabine and Tenofovir Disoproxil Fumarate, 42543-719 — EMTRICITABINE and TENOFOVIR Disoproxil Fumarate, 49502-450 — Lamivudine and Tenofovir Disoproxil Fumarate, 49502-475 — Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate, 50090-6247 — bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate, 50090-7202 — Tenofovir Disoproxil Fumarate, 50090-7719 — Emtricitabine and tenofovir disoproxil fumarate, 50090-8028 — Emtricitabine and tenofovir disoproxil fumarate, 50268-758 — tenofovir disoproxil fumarate, 51407-112 — EMTRICITABINE and TENOFOVIR Disoproxil Fumarate, 59651-165 — Emtricitabine and Tenofovir Disoproxil Fumarate, 59651-166 — Emtricitabine and Tenofovir Disoproxil Fumarate, 59651-167 — Emtricitabine and Tenofovir Disoproxil Fumarate, 59676-800 — Darunavir, Cobicistat, Emtricitabine, and Tenofovir alafenamide, 60219-2095 — Emtricitabine and Tenofovir Disoproxil Fumarate, +82 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels